• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    Merck KGaA, Quris-AI Expand Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC

    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Federal Equipment Company

    Bachem

    INCOG BioPharma Services

    CMC Pharmaceuticals

    AMERIPHARMA
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Federal Equipment Company

    Bachem

    INCOG BioPharma Services

    CMC Pharmaceuticals

    AMERIPHARMA
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Cold Chain Market and Technology Trends

    Advanced technologies for cold chain management to ensure drug safety and efficacy continue to grow in importance.

    Cold Chain Market and Technology Trends
    Cold Chain Market and Technology Trends
    Cold Chain Market and Technology Trends
    Mark Sawicki, Cryoport09.06.17
    The cold chain pharmaceutical market, currently estimated to be in excess of $13.4 billion in 2017, continues to be one garnering specific interest within the logistics space. New therapies such as regenerative therapies and gene therapies as well as a shift toward temperature-managed shipments are currently of significant focus. This is due to the fact that many of the most innovative therapeutics, like regenerative medicines and other advanced cell-based therapies, are close to commercial launch and need to be shipped under very exacting temperature conditions. This shift is contributing to the growth of temperature-controlled products at more than twice the rate of non-temperature-controlled products. Evidence of market interest in the space is evidenced by recent investments, acquisitions such as UPS acquiring Marken and QuickStat’s acquisition of Unitrans, as well as business expansion, including Almac launching their TempEZ service, and Cryoport’s C3, 2-8°C service.

    Additionally, The Drug Supply Chain Security Act (DSCSA), along with FDA 21 CFR GMP and GDP requirements, have turned a spotlight on the value of these intelligent temperature-controlled materials requiring better transportation solutions than what has been in the market in recent years. Many companies have turned their focus on three primary areas to respond to these requirements; namely enhanced, reusable packaging, real-time data monitoring, as well as advanced informatics systems to support in transit logistics considerations. Each of these focus areas require their own specific know how as well as state-of-the-art advancements to support the enhanced scrutiny. We will discuss each of them independently. 

    Packaging
    There has been considerable focus on the development of packaging equipment with improved properties over conventional insulated packages. Significant efforts have been made on improved vacuum insulated panels, on-demand systems that do not require pre-conditioning, as well as flexible, actively temperature managed solutions that are now emerging, each with their own strengths and weaknesses, as well as a shift away from outdated solutions such as dry ice toward cryogenic distribution. The common feature with many of these newly emerging technologies is the fact that these shipping systems are reusable and require well developed reverse logistics as well as cleaning procedures to ensure that there is no outside or cross-contamination which poses its own challenges.

    Development of consistent, effective decontamination processes poses its own unique challenges. Each type of equipment has its own unique materials, which may be impacted negatively by different solvents commonly utilized in laboratory or clean room disinfection. Alternative, non-contact means of decontamination would be advantageous and could have utility across a wide range of packaging materials. One of these new technologies being developed within the transportation space is xenon-pulsed ultraviolet light disinfection. Pulsed xenon-based ultraviolet light no-touch disinfection systems are being increasingly used for hospital room disinfection after patient discharge. These systems have been shown in multiple studies to effectively reduce aerobic bacteria in the absence of manual disinfection1. In some of the studies, PX-UV exposure resulted in a 5-log CFU reduction for multidrug-resistant organisms (MDROs) on spiked plates. Cryoport is actively developing a xenon-pulsed ultraviolet light disinfection system for its cryogenic and C3 shippers, providing enhanced disinfection as well as the ability to disinfect at cryogenic temperatures, reducing processing time and increasing the number of turns a piece of equipment can be used within a set period. These methods are being developed to reduce cost of goods as well as improve overall equipment performance.

    Data monitoring
    As mentioned earlier, in 2018, one out of every two pharmaceutical products will be thermo sensitive and will require to be temperature monitored from point of manufacturing to ‘last mile’ delivery. The DSCSA is also pushing companies to adopt newer technologies for chain of condition and chain of custody adherence. Next generation data loggers are now readily present and can track an entire range of specifications in near real time such as location, temperature (inside and out), shock, orientation, anti-tamper, humidity, and pressure.

    Most of these devices use lithium metal or lithium ion cells or batteries as a power source. Lithium cells and batteries are classified as dangerous goods and therefore must meet all of the applicable provisions of the Dangerous Goods Regulations (DGR) when shipped by air. This applies regardless of whether the lithium cells or batteries are shipped as cargo in their own right or whether the lithium cells or batteries are installed in a small device such as a data logger that is placed inside or attached to packages of cargo. In addition, to be permitted in transport all lithium cell and battery types must have passed the applicable tests set out in Subsection 38.3 of the UN Manual of Tests and Criteria.
    Packages containing lithium batteries installed in equipment such as a data logger may or may not require the lithium battery mark as shown in Figure 7.1.C of the IATA DGR (see Figure 1). The lithium battery mark is not required on packages where there are no more than 4 cells or 2 batteries contained in equipment in each package and there are no more than two packages in the consignment. These limitations may restrict the lifecycle management and lifespan of next generation data loggers in the near future and must be monitored carefully by the industry.

    Informatics
    It has become clear that effective cold chain logistics management is vitally important to preserving the efficacy of valuable cold chain dependent medicines and for risk mitigation. Unfortunately, most companies do not integrate logistics planning early enough in their clinical trial design, it is often an afterthought once the product is nearing commercialization. Adding complexity, such as adding more links to a supply chain as seen in regenerative therapy programs (see Figure 2), increases the steps and/or temperatures that must be controlled and increases risk of a temperature excursion.

    Next generation informatics systems must have the ability to not only collect location and handling information from in field scan codes and airline data, it needs to effectively manage the validation and qualification data for the packaging, as well as verify and control the performance, calibration, and reconditioning status of the packaging, collect and correlate real time data collected from data loggers in the field as well as assess performance and cost of selected logistics partners. In addition, the informatics systems that are required to manage an ever-increasing complex supply chain must have the ability to not only actively monitor the logistics conditions and considerations around any given product distribution, it must also be able to interpret the data coming in from the next generation data loggers in real time, assess risk intelligently, and support defined SOP’s related to escalation procedures if an exception requiring intervention is observed.

    Conclusion
    As an ever-increasing number of cold-chain dependent therapies move from the bench into clinical trials and finally to approval, and regulatory requirements for packaging, and chain of custody increase, the specialized packaging, tracking, and data capture requirements for these highly valuable and temperature-sensitive biological materials will need to keep pace. Advanced technologies for cold chain management to ensure their safety and efficacy when they reach the patient will become of paramount importance. Next generation packaging technologies, advanced package tracking, intelligent informatics systems and knowledge of international regulations can provide tools that companies and logistics managers need to reduce the risk of failure due to cold chain logistics issues. 

    References
    Deverick J. Anderson, Maria F. Gergen, MT, Emily Smathers, Daniel J. Sexton, Luke F. Chen, David J. Weber, William A. Rutala, (2013) Decontamination of Targeted Pathogens from Patient Rooms Using an Automated Ultraviolet-C-Emitting Device; Infection Control and Hospital Epidemiology, 34, 466-471.


    Mark W. Sawicki, PhD, is chief commercial officer at Cryoport. With more than 15 years of business development and sales management experience in senior leadership roles, he has a proven record of consistently delivering on corporate revenue and market share goals in the pharmaceutical and biotechnology industries. Dr. Sawicki holds a doctorate in biochemistry from the State University of New York at Buffalo, School of Medicine and Biomedical Sciences. He also received graduate training at the Hauptman Woodard Medical Research Institute and has authored numerous scientific publications in drug discovery with a focus on oncology and immunology. He can be reached via email at msawicki@cryoport.com.
    Related Searches
    • acquisition
    • Development
    • training
    • expansion
    Suggested For You
    Tower Cold Chain to Open New Global Headquarters in the UK Tower Cold Chain to Open New Global Headquarters in the UK
    UK Govt. Terminates Valneva COVID Vax Agreement UK Govt. Terminates Valneva COVID Vax Agreement
    Flexible Ultracold Chain Critical to Decentralized Clinical Trials Flexible Ultracold Chain Critical to Decentralized Clinical Trials
    Fortifying Logistics with Technology for Decentralized Trials Fortifying Logistics with Technology for Decentralized Trials
    CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers
    A Look Into COVID Vaccines, Development and Outsourcing A Look Into COVID Vaccines, Development and Outsourcing
    Clinical Trial Supply Services Clinical Trial Supply Services
    Catalent and Stirling Ultracold Enter Cold Chain Partnership Catalent and Stirling Ultracold Enter Cold Chain Partnership
    CSafe Global Appoints SVP of Technology and Innovation CSafe Global Appoints SVP of Technology and Innovation
    Vetter Packaging Solutions Vetter Packaging Solutions
    Cold-Chain Handling Is Not Just a COVID Vaccine Challenge Cold-Chain Handling Is Not Just a COVID Vaccine Challenge
    WDSRX Establishes National 3PL Presence WDSRX Establishes National 3PL Presence
    PCI Pharma Services Expands Cold Chain Clinical Supply Storage PCI Pharma Services Expands Cold Chain Clinical Supply Storage
    Altimmune, Lonza Expand AdCOVID Manufacturing Pact Altimmune, Lonza Expand AdCOVID Manufacturing Pact
    J&J’s Single-Dose COVID-19 Vax Issued EUA J&J’s Single-Dose COVID-19 Vax Issued EUA

    Related Breaking News

    • Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking
      Tower Cold Chain to Open New Global Headquarters in the UK

      Tower Cold Chain to Open New Global Headquarters in the UK

      The 26,000 sq. ft building will greatly expand Tower’s container conditioning and storage capacities.
      09.16.21

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      UK Govt. Terminates Valneva COVID Vax Agreement

      UK Govt. Terminates Valneva COVID Vax Agreement

      Valneva is continuing its VLA2001 development plan with Phase III results expected 4Q21 and potential MHRA approval in late 2021.
      09.13.21

    • Clinical Trials | Cold Chain Management | Logistics
      Flexible Ultracold Chain Critical to Decentralized Clinical Trials

      Flexible Ultracold Chain Critical to Decentralized Clinical Trials

      Addressing barriers to further grow and accelerate the adoption of patient-focused DCTs.
      Timothy Root, Marketing Director, Stirling Ultracold 08.12.21


    • Clinical Trials | Logistics
      Fortifying Logistics with Technology for Decentralized Trials

      Fortifying Logistics with Technology for Decentralized Trials

      UPS Healthcare President Wes Wheeler shares insights on key challenges associated with decentralized clinical trials and how they can be overcome.
      Kristin Brooks, Managing Editor, Contract Pharma 08.11.21

    • Analytical Services | Biologics, Proteins, Vaccines | Cold Chain Management | GMPs/GCPs | Scale-up/Technology Transfer | Serialization | Solid Dosage/Semi-solids | Vials
      CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers

      CMO Becoming a Powerhouse With Expansions and New Facilities, Looking to Add Strategic Customers

      Aphena is a service provider in the pharmaceutical, OTC, medical device, biologics and personal care industries.

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    • Merck KGaA, Quris-AI Expand Collaboration
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    AkzoNobel Shares Sustainable Architectural Solutions at Conference
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    ResMed, Nyxoah Team Up to Grow Sleep Apnea Awareness & Therapy in Germany
    Siemens Healthineers’ Magnetom Viato.Mobile Cleared by FDA
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Phase I Clinical Milestone for New Depression Treat
    Sanner Group Opens Second Manufacturing Facility in China
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Stoelzle Glass Group Names New CEO
    Happi

    Latest Breaking News From Happi

    Breakfast with Oral Care Benefits?
    Stanford Researchers Study Skin and Sensorial Perception
    L’Oréal Awarded US Patent for Makeup
    Ink World

    Latest Breaking News From Ink World

    Siegwerk’s Climate Targets Validated by SBTi
    ROSS Offering Cost-Effective, Expertly Reconditioned Equipment
    Amcor plc Adds Lucrèce Foufopoulos-De Ridder to Board of Directors
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Centinel Spine prodisc System Surpasses 2,500-Implant Milestone
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More
    SCHOTT Strengthens Glass Substrate Portfolio

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login